Management of chronic thromboembolic pulmonary hypertension (CTEPH) includes multimodal therapy that depends on expert ...

A new study published in Nanotechnology offers new hope for less harmful breast cancer therapy by combining two powerful, non ...

Along with weight loss, Faubion’s study found that both groups of women on semaglutide drugs showed improvement in heart health measures like A1C (a marker for diabetes) and blood pressure, although ...

Tagrisso with chemo significantly improved survival and progression-free outcomes versus Tagrisso alone in newly diagnosed ...

Dupilumab in combination with other biologic agents is safe and effective for treating various chronic inflammatory conditions.

City of Hope Research Spotlight offers a glimpse into groundbreaking scientific and clinical discoveries advancing lifesaving ...

Monjuvi added to Rituxan and Revlimid extended progression-free survival from 14 to 22 months in follicular lymphoma, ...

Further, the company plans to initiate additional atebimetinib clinical trial combination arms in 2026, exploring its potential in other indications or in combination with other agents. REFERENCES: 1.

Early combo therapy after a heart attack lowers cholesterol faster and cuts heart risks more than statins alone. (CREDIT: Africa Studio / Shutterstock) ...

Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.

Combination therapy in mHSPC has increased, improving overall survival compared with ADT monotherapy. No significant OS difference exists between ARPI and docetaxel combinations, but ARPI offers ...

with ICT01 Combination Therapy at ASCO 2025 ICT01 in combination with azacitidine and venetoclax (Aza-Ven) achieves unprecedented high remission rates overall and across molecular subtypes in ...